References
- Alimenti, A., Forbes, J. C., Oberlander, T. F., Money, D. M., Grunau, R. E., Papsdorf, M. P., … Burdge, D. R. (2006). A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy. Pediatrics, 118, e1139–e1145. doi: 10.1542/peds.2006-0525
- Beery, K. E., Buktenica, N. A., Beery, N. A. (2010). Beery-Buktenica developmental test of visual motor integration (6th ed.). Minneapolis, MN: Pearson Assessment.
- Blanche, S., Tardieu, M., Rustin, P., Slama, A., Barret, B., Firtion, G., … Desguerre, I. (1999). Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. The Lancet, 354, 1084–1089. doi: 10.1016/S0140-6736(99)07219-0
- Caniglia, E. C., Patel, K., Huo, Y., Williams, P. L., Kapetanovic, S., Rich, K. C., … Seage III, G. R. (2016). Atazanavir exposure in utero and neurodevelopment in infants: a comparative safety study. AIDS, 30, 1267–1277. doi: 10.1097/QAD.0000000000001052
- Culnane, M., Fowler, M. G., Lee, S. S., McSherry, G., Brady, M., O’Donnell, K., … Jimenez, E. (1999). Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Journal of the American Medical Association, 281, 151–157. Retrieved from http://jama.jamanetwork.com/article.aspx?articleid=188355 doi: 10.1001/jama.281.2.151
- Evans, C., Jones, C. E., & Prendergast, A. J. (2016). HIV-exposed, uninfected infants: New global challenges in the era of paediatric HIV elimination. The Lancet Infectious Diseases, 16, e92–e107. doi: 10.1016/S1473-3099(16)00055-4
- Garvie, P.A., Zeldow, B., Malee K., Nichols, S.L., Smith, R.A., Wilkins, M.L., Williams, P.L. (2014). Discordance of cognitive and academic achievement outcomes in youth with perinatal HIV exposure. The Pediatric Infectious Disease Journal, 33, e232–e238. doi: 10.1097/INF.0000000000000314
- Hoff, E., & Tian, C. (2005). Socioeconomic status and cultural influences on language. Journal of Communication Disorders, 38, 271–278. doi: 10.1016/j.jcomdis.2005.02.003
- Kerr, S. J., Puthanakit, T., Vibol, U., Aurpibul, L., Vonthanak, S., Kosalaraksa, P., … Ratanadilok, K. (2014). Neurodevelopmental outcomes in HIV-exposed-uninfected children versus those not exposed to HIV. AIDS Care, 26, 1327–1335. doi: 10.1080/09540121.2014.920949
- Magnuson, K., Lahaie, C., & Waldfogel, J. (2006). Preschool and school readiness of children of immigrants. Social Science Quarterly, 87, 1241–1262. doi:10.1111/j.15406237.2006.00426.x
- Ngoma, M. S., Hunter, J. A., Harper, J. A., Church, P. T., Mumba, S., Chandwe, M., … Sandstrom, P. A. (2014). Cognitive and language outcomes in HIV-uninfected infants exposed to combined antiretroviral therapy in utero and through extended breast-feeding. AIDS, 28, S323–S330. doi: 10.1097/QAD.0000000000000357
- Nozyce, M. L., Huo, Y., Williams, P. L., Kapetanovic, S., Hazra, R., Nichols, S., … Sirois, P. A. (2014). Safety of in utero and neonatal ARV exposure: Cognitive and academic outcomes in HIV-exposed, uninfected children 5–13 years of age. The Pediatric Infectious Disease Journal, 33, 1128–1133. doi: 10.1097/INF.0000000000000410
- Rauh, V. A., Parker, F. L., Garfinkel, R. S., Perry, J., & Andrews, H. F. (2003). Biological, social, and community influences on third-grade reading levels of minority head start children: A multilevel approach. Journal of Community Psychology, 31, 255–278. doi: 10.1002/jcop.10049
- Rice, M. L., Zeldow, B., Siberry, G. K., Purswani, M., Malee, K., Hoffman, H. J., … Williams, P. L. (2013). Evaluation of risk for late language emergence after in utero antiretroviral drug exposure in HIV-exposed uninfected infants. The Pediatric Infectious Disease Journal, 32, e406–e413. doi: 10.1097/INF.0b013e31829b80ee
- Sherr, L., Croome, N., Castaneda, K. P., & Bradshaw, K. (2014). A systematic review of psychological functioning of children exposed to HIV: Using evidence to plan for tomorrow’s HIV needs. AIDS and Behavior, 18, 2059–2074. doi: 10.1007/s10461-014-0747-6
- Sirois, P. A., Huo, Y., Williams, P. L., Malee, K., Garvie, P. A., Kammerer, B., … Nozyce, M. L. (2013). Safety of perinatal exposure to antiretroviral medications: Developmental outcomes in infants. The Pediatric Infectious Disease Journal, 32, 648–655. doi: 10.1097/INF.0b013e318284129a
- Sparrow, S. S., Cicchetti, D. V., & Balla, D. A. (2005). Vineland adaptive behavior scales (2nd ed.). Minneapolis, MN: Pearson Assessment.
- Spaulding, A. B., Yu, Q., Civitello, L., Mussi-Pinhata, M. M., Pinto, J., Gomes, I. M., … Hazra, R. (2016). Neurologic outcomes in HIV-exposed/uninfected infants exposed to antiretroviral drugs during pregnancy in latin America and the caribbean. AIDS Research and Human Retroviruses, 32, 349–356. doi: 10.1089/aid.2015.0254
- Wechsler, D. (2002). WPPSI-III technical and interpretive manual. San Antonio, TX: The Psychological Corp.
- Williams, P. L., Marino, M., Malee, K., Brogly, S., Hughes, M. D., Mofenson, L. M., & PACTG 219C Team. (2010). Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants. Pediatrics, 125, e250–e260. doi: 10.1542/peds.2009-1112